Unprecedented Phase 1 CML efficacy data and potential best-in-disease profile of TERN-701 featured in ASH 2025 abstract Upcoming ASH oral ...
TipRanks on MSN
CML Microsystems Updates on Share Options and Voting Rights
More about CML Microsystems. CML Microsystems Plc develops mixed-signal, RF, and microwave semiconductors for global comm ...
A lower number of CD26+ LSCs at diagnosis correlates with optimal molecular response in CML patients at 3, 12, and 24 months.
Chicago Magic Lounge will present the debut of Magic is People, a new one-man show by founding company member and audience ...
Lucknow: Chronic Myeloid Leukemia (CML) — which forms a major share of adult blood cancer cases in Uttar Pradesh — can now be ...
Alembic Pharma received USFDA approval for its generic Dasatinib Tablets (20–140 mg), equivalent to Sprycel by BMS. The drug ...
Terns Pharmaceuticals (TERN) is getting attention after announcing that early-stage trial results for its CML drug candidate, TERN-701, were selected for oral presentation at this year's American ...
In October 2025, Terns Pharmaceuticals announced strongly positive Phase 1 data for TERN-701 in chronic myeloid leukemia, with a 75% major molecular response rate by 24 weeks and no dose-limiting ...
Detailed price information for Terns Pharmaceuticals Inc (TERN-Q) from The Globe and Mail including charting and trades.
Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Dasatinib tablets, a treatment for certain types of blood cancer.
The first look of Cynthia Erivo in Prima Facie has been revealed, plus a supporting cast including Daniel Ings, Noma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback